| Biomarker ID | 1059 |
| PMID | 23374809 |
| Year | 2012 |
| Biomarker | Dehydroepiandrosterone sulfate (DHEA-S) |
| Biomarker Basis | Concentration Based (ng/ml) |
| Biomolecule | Metabolites |
| Source | Serum |
| Subjects | Humans |
| Regulation | Downregulated with Androgen Deprivation Therapy (Before: 133.3 ±63.8; After: 83.4 ± 51.4) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Before and after androgen Deprivation therapy (ADT) |
| Type of Biomarker | Predictive |
| Cohort | 72 patients who underwent radiation and had never undergone previous therapy were included in the study. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | NA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |